Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Principal component analysis did not suggest differences in linear combinations of 25(OH)D, the VDMR, PTH, and FGF‐23 between participants who experienced fractures and those who did not.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The mean age of participants was 62 ± 10 years, and 53% were female.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Biomarkers of Vitamin D Metabolism and Hip and Vertebral Fracture Risk: The Multi‐Ethnic Study of Atherosclerosis

Study design awaiting verification · JBMR Plus · 2022

Original publication title

Biomarkers of Vitamin D Metabolism and Hip and Vertebral Fracture Risk: The Multi‐Ethnic Study of Atherosclerosis

Simon Hsu; Michael H. Criqui; Charles Ginsberg; Andrew N. Hoofnagle; Joachim H. Ix; Robyn L. McClelland; Erin D. Michos; Steven J. Shea; David Siscovick; Leila R. Zelnick; Bryan R. Kestenbaum; Ian H. de Boer

© 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

ABSTRACT

Studies on associations between biomarkers of vitamin D metabolism and fracture risk have focused predominantly on White or elderly populations and may not be generalizable to relatively healthy multiethnic populations. We tested associations of total 25‐hydroxyvitamin D (25[OH]D), the ratio of 24,25‐dihydroxyvitamin D3 to 25‐hydroxyvitamin D3 (vitamin D metabolite ratio, VDMR), parathyroid hormone (PTH), and fibroblast growth factor‐23 (FGF‐23) concentrations measured in serum with risk of hip and vertebral fractures in the Multi‐Ethnic Study of Atherosclerosis (MESA). Serum 25‐hydroxyvitamin D2 and D3 and 24,25‐dihydroxyvitamin D3 were measured by liquid chromatography: tandem mass spectrometry (LC: MS/MS).

The study cohort of 6466 participants was without clinically apparent cardiovascular disease and was 39% White, 27% Black, 22% Hispanic, and 12% Chinese. The mean age was 62 years, and 53% were female. There were 128 hip and vertebral fractures over a mean follow‐up of 14.2 years. 25(OH)D, the VDMR, PTH, and FGF‐23 were not significantly associated with fracture risk after adjustment for demographics, diabetes, smoking, systolic blood pressure, body mass index, medication use, albuminuria, and estimated glomerular filtration rate.

Principal component analysis did not suggest differences in linear combinations of 25(OH)D, the VDMR, PTH, and FGF‐23 between participants who experienced fractures and those who did not. We did not observe significant interaction between race and ethnicity and any biomarker of vitamin D metabolism on fracture risk. In conclusion, none of the four serum biomarkers of vitamin D metabolism investigated showed a significant association with fracture risk in relatively healthy multiethnic populations. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

Authors’ abstract

ABSTRACT

Studies on associations between biomarkers of vitamin D metabolism and fracture risk have focused predominantly on White or elderly populations and may not be generalizable to relatively healthy multiethnic populations. We tested associations of total 25‐hydroxyvitamin D (25[OH]D), the ratio of 24,25‐dihydroxyvitamin D3 to 25‐hydroxyvitamin D3 (vitamin D metabolite ratio, VDMR), parathyroid hormone (PTH), and fibroblast growth factor‐23 (FGF‐23) concentrations measured in serum with risk of hip and vertebral fractures in the Multi‐Ethnic Study of Atherosclerosis (MESA). Serum 25‐hydroxyvitamin D2 and D3 and 24,25‐dihydroxyvitamin D3 were measured by liquid chromatography: tandem mass spectrometry (LC: MS/MS).

The study cohort of 6466 participants was without clinically apparent cardiovascular disease and was 39% White, 27% Black, 22% Hispanic, and 12% Chinese. The mean age was 62 years, and 53% were female. There were 128 hip and vertebral fractures over a mean follow‐up of 14.2 years. 25(OH)D, the VDMR, PTH, and FGF‐23 were not significantly associated with fracture risk after adjustment for demographics, diabetes, smoking, systolic blood pressure, body mass index, medication use, albuminuria, and estimated glomerular filtration rate.

Principal component analysis did not suggest differences in linear combinations of 25(OH)D, the VDMR, PTH, and FGF‐23 between participants who experienced fractures and those who did not. We did not observe significant interaction between race and ethnicity and any biomarker of vitamin D metabolism on fracture risk. In conclusion, none of the four serum biomarkers of vitamin D metabolism investigated showed a significant association with fracture risk in relatively healthy multiethnic populations. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

Publication and source details

Original title: Biomarkers of Vitamin D Metabolism and Hip and Vertebral Fracture Risk: The Multi‐Ethnic Study of Atherosclerosis

Simon Hsu; Michael H. Criqui; Charles Ginsberg; Andrew N. Hoofnagle; Joachim H. Ix; Robyn L. McClelland; Erin D. Michos; Steven J. Shea; David Siscovick; Leila R. Zelnick; Bryan R. Kestenbaum; Ian H. de Boer

JBMR Plus · 2022

* Address correspondence to: Simon Hsu, MD, MS, Division of Nephrology and Kidney Research Institute, Department of Medicine, University of Washington, 325 9 Avenue, Box 359606, Seattle, WA 98104, USA. E‐mail: sihsu@uw.edu
© 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.National Center for Advancing Translational Sciences 10.13039/100006108National Heart, Lung, and Blood Institute 10.13039/100000050National Institute of Diabetes and Digestive and Kidney Diseases 10.13039/100000062

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T08:28:30.967629+00:00

DOI: 10.1002/jbm4.10697 · PMC9751658